Gerrit Cole’s latest elbow saga kicked off Thursday, March 6, 2025, during a spring training outing against the Minnesota Twins. The Yankees’ ace surrendered six runs in 2⅔ innings—not the kind of stat line you expect from a guy who pocketed the 2023 AL Cy Young Award and carries a $324 million, nine-year contract. After the game, Cole sounded optimistic, almost smug, touting his fastball velocity (95.7 mph average, peaking at 97.6) and claiming he felt better than he had in a while. Fast forward to Saturday, March 8, and that same elbow’s got him “concerned,” waiting on a second opinion after an MRI revealed something funky post-outing. For Yankees fans, it’s a grim rerun of last spring, when nerve irritation and edema sidelined him until June 19, 2024—yet he still salvaged a 3.41 ERA over 17 starts and dominated the postseason with a 2.17 ERA in four outings.
This isn’t just déjà vu; it’s déjà vu with a side of dread. Cole’s elbow has become the friend who swears they’re fine after a night out, only to call you from the ER at 3 a.m. Last year, he dodged the Tommy John bullet—a surgery that’s become baseball’s grim reaper for pitchers—and returned to anchor the Yankees’ World Series run. To avoid a repeat, he tweaked his offseason routine, starting his throwing program in November instead of December. Early signs were promising: his first spring start on February 28 featured five strikeouts over 3⅓ innings, with velo ticking up to levels that had scouts nodding approvingly. But after Thursday’s Twins debacle, soreness crept in, and now he’s stuck in diagnostic purgatory. “I’m hoping for the best,” he told reporters Saturday, a line that lands somewhere between cautious optimism and a plea for mercy.
The Yankees’ front office isn’t laughing. Cole’s their cornerstone, the guy they banked on to lead a rotation that lost Juan Soto’s bat this offseason but gained Max Fried’s arm for $218 million. Last year’s injury was a speed bump—17 starts was enough to keep them in contention—but a longer absence now could derail 2025 before it starts. His 2024 regular season wasn’t vintage (3.41 ERA, 5-5 record), but his postseason resurgence reminded everyone why he’s worth nine figures. The Twins game wasn’t a total disaster—his fastball still had zip, and he mixed in sliders and cutters—but the aftermath has everyone on edge. Was it the workload? The cold Florida air? Or is this elbow just tired of carrying the weight of a franchise?
For those who dig into the nuts and bolts, there’s a biomechanical angle worth chewing on. Cole’s fastball averaged 97.5 mph in 2024, down slightly from his 2023 peak but still elite. His delivery’s a high-torque marvel, generating spin rates (2,400+ rpm on the four-seamer) that make hitters flail. But that torque comes with a cost. Last spring, he threw 13 breaking pitches in a bullpen session before the elbow flared up—sliders and cutters that stress the ulnar collateral ligament more than a straight fastball. This year’s early throwing program might’ve overtaxed an arm already flirting with its limits. He’s 34 now, not old by pitcher standards, but the mileage—2,152 career innings, including postseason—adds up. If this MRI whispers “Tommy John,” we’re talking 18 months minimum, sidelining him through most of 2025 and into 2026. That’s not a hiccup; that’s a gut punch to a team with a creaky World Series window.
What’s next? The second opinion could come as early as Monday, March 10, but until then, speculation rules. If it’s just inflammation, a few weeks of rest might suffice—similar to last year’s recovery arc. If it’s a partial tear, platelet-rich plasma injections could buy time, though that’s a Band-Aid on a potential time bomb. Surgery’s the nuclear option, and the Yankees would lean hard on Fried, Carlos Rodón, and prospects like Will Warren, who’s looked sharp this spring. Rodón’s own injury history (shoulder, forearm issues) doesn’t inspire confidence, and Fried’s a Cy Young-caliber arm but not a workhorse (162 innings in 2024). The bullpen’s already thin with Scott Effross down, so a Cole-sized hole could force a trade—think Sandy Alcántara or a reunion with Jordan Montgomery.
Fans are split. Some see this as par for the course—pitchers break, Cole’s tough, he’ll be back. Others are doomscrolling X, convinced the season’s cursed before Opening Day. The truth’s in the middle: Cole’s elbow isn’t a death sentence yet, but it’s a warning. The Yankees built this roster to win now, not to limp through another injury-riddled campaign. For now, they wait, and Cole’s arm holds the keys to their summer. One thing’s clear: $324 million buys a lot of talent, but it can’t buy peace of mind.
Leave a comment